TopicNeuroscience

epigenetic editing

Content Overview
4Total items
2Seminars
2ePosters

Latest

SeminarNeuroscience

Rett syndrome, MECP2 and therapeutic strategies

Rudolf Jaenisch
Whitehead Institute for Biomedical Research and Department of Biology, MIT, Cambridge, USA
Dec 11, 2024

The development of the iPS cell technology has revolutionized our ability to study development and diseases in defined in vitro cell culture systems. The talk will focus on Rett Syndrome and discuss two topics: (i) the use of gene editing as an approach to therapy and (ii) the role of MECP2 in gene expression (i) The mutation of the X-linked MECP2 gene is causative for the disease. In a female patient, every cell has a wt copy that is, however, in 50% of the cells located on the inactive X chromosome. We have used epigenetic gene editing tools to activate the wt MECP2 allele on the inactive X chromosome. (ii) MECP2 is thought to act as repressor of gene expression. I will present data which show that MECP2 binds to Pol II and acts as an activator for thousands of genes. The target genes are significantly enriched for Autism related genes. Our data challenge the established model of MECP2’s role in gene expression and suggest novel therapeutic approaches.

SeminarNeuroscienceRecording

Epigenetic regulation of alternative splicing in the context of cocaine reward

Elizabeth A Heller, PhD
The University of Pennsylvania, Penn Epigenetics Institute, Systems Pharmacology & Translational Therapeutics
Oct 6, 2021

Neuronal alternative splicing is a key gene regulatory mechanism in the brain. However, the spliceosome machinery is insufficient to fully specify splicing complexity. In considering the role of the epigenome in activity-dependent alternative splicing, we and others find the histone modification H3K36me3 to be a putative splicing regulator. In this study, we found that mouse cocaine self-administration caused widespread differential alternative splicing, concomitant with the enrichment of H3K36me3 at differentially spliced junctions. Importantly, only targeted epigenetic editing can distinguish between a direct role of H3K36me3 in splicing and an indirect role via regulation of splice factor expression elsewhere on the genome. We targeted Srsf11, which was both alternatively spliced and H3K36me3 enriched in the brain following cocaine self-administration. Epigenetic editing of H3K36me3 at Srsf11 was sufficient to drive its alternative splicing and enhanced cocaine self-administration, establishing the direct causal relevance of H3K36me3 to alternative splicing of Srsf11 and to reward behavior.

ePosterNeuroscience

CRISPR-based epigenetic editing of engram cells in fear memories

Davide Martino Coda, Lisa Watt, Lilliane Glauser, Johannes Graff
ePosterNeuroscience

CRISPR-based epigenetic editing of engram cells in fear memories

Davide Martino Coda, Johannes Graeff

FENS Forum 2024

epigenetic editing coverage

4 items

Seminar2
ePoster2

Share your knowledge

Know something about epigenetic editing? Help the community by contributing seminars, talks, or research.

Contribute content
Domain spotlight

Explore how epigenetic editing research is advancing inside Neuroscience.

Visit domain

Cookies

We use essential cookies to run the site. Analytics cookies are optional and help us improve World Wide. Learn more.